• Home
  • IMV imaging blog
  • Montagu Private Equity & Qualium Investissement and management to acquire IMV Technologies

Montagu Private Equity & Qualium Investissement and management to acquire IMV Technologies

PressRelease.AcquisitionofIMVTech.200121

Paris, 20 January 2021 – Montagu Private Equity (“Montagu”), a leading European private equity firm, announces today that it has entered exclusive negotiations with Qualium Investissement and management to acquire IMV Technologies.

Based in Normandy, France, IMV Technologies is the world leader in the design, manufacture, distribution and service of equipment and supplies used in animal reproduction and animal reproductive and clinical imaging. Its Life Sciences division features products used in human medical research and assisted reproduction. With operations in France, Brazil, China, India, the Netherlands, Russia, South Africa, the United Kingdom and the United States, and a vast network of distributors across more than 120 countries, IMV Technologies generates more than 85% of its revenue internationally.

IMV Technologies’ management team, supported by Qualium Investissement, has considerably grown the business through seven acquisitions and continued investments in R&D, which have allowed it to broaden its expertise and strengthen its global leadership in animal artificial insemination.

Alain de Lambilly, CEO of IMV Technologies, said: “We are delighted to be partnering with Montagu and see considerable opportunity ahead. The firm’s deep expertise in the healthcare and technology sectors will be a major asset for our company. Montagu’s partnership will enable us to further develop the company through significant investments in research and innovation. IMV Technologies thanks Qualium Investissement for bringing us to this place in our journey.”

Guillaume Jabalot, Director at Montagu, said: “The management team has accelerated growth and innovation at IMV Technologies, reinforced its leadership position globally and opened new growth avenues. The company operates in markets offering both long-term growth prospects and resilience, two core features of Montagu’s investment strategy. We are delighted to be partnering with management and supporting them in their growth strategy, both in France and internationally. With our backing, IMV Technologies will be able to continue its success as a consolidation platform in an industry which remains fragmented.”

Jacques Pancrazi, Partner of Qualium Investissement, said: “We are delighted to have supported IMV’s management team in its growth journey over the past six years. Continuing the work accomplished during Gilles de Robert’s 15-year leadership, Alain de Lambilly and his team have explored new avenues of growth through continued investment in innovation. This consistent focus on offering high value-added solutions to customers should further accelerate the company’s growth over the coming years.”

The transaction is subject to the final and definitive agreement between the parties and customary conditions and provisions.

 

Advisors to the buyer
- M&A: Rothschild & Co
- Financial Due Diligence: Alvarez & Marsal
- Commercial Due Diligence: Bain & Company
- Legal and Tax Due Diligence: PwC Société d’Avocats
- Lawyers: Weil, Gotshal & Manges LLP

Advisors to the seller
- M&A: Goldman Sachs
- Financial Due Diligence: PwC
- Commercial Due Diligence: Boston Consulting Group, JHNext
- Lawyers: Willkie Farr & Gallagher

Subscribe to newsletter

Goat and sheep management with ultrasound IMV imaging release NEW equine stifle how-to videos

IMV imaging on LinkedIn

Follow us on Linkedin for the latest news, clinical materials and more.

IMV imaging on LinkedIn

IMV imaging on YouTube

Follow us on YouTube for the latest news, clinical materials and more.

IMV imaging YouTube